Literatuurreferenties
1. Algra A, et al. Aspirin in primary prevention: sex and baseline risk matter. Lancet 2009; 373: 1821-1822.
2. Antithrombotic Trialists’ (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-1860.